Wells CD - Search Results

1

Clinical outcome of individualised treatment of multidrug-resistant tuberculosis in Latvia: a retrospective cohort study.

Leimane V, Riekstina V, Holtz TH, Zarovska E, Skripconoka V, Thorpe LE, Laserson KF, Wells CD. Leimane V, et al. Among authors: wells cd. Lancet. 2005 Jan 22-28;365(9456):318-26. doi: 10.1016/S0140-6736(05)17786-1. Lancet. 2005. PMID: 15664227

2

Seasonality of tuberculosis in India: is it real and what does it tell us?

Thorpe LE, Frieden TR, Laserson KF, Wells C, Khatri GR. Thorpe LE, et al. Lancet. 2004 Oct 30-Nov 5;364(9445):1613-4. doi: 10.1016/S0140-6736(04)17316-9. Lancet. 2004. PMID: 15519633

3

Multidrug-resistant tuberculosis detection, Latvia.

Skenders G, Fry AM, Prokopovica I, Greckoseja S, Broka L, Metchock B, Holtz TH, Wells CD, Leimane V. Skenders G, et al. Among authors: wells cd. Emerg Infect Dis. 2005 Sep;11(9):1461-3. doi: 10.3201/eid1109.041236. Emerg Infect Dis. 2005. PMID: 16229783 Free PMC article. Clinical Trial.

4

Time to sputum culture conversion in multidrug-resistant tuberculosis: predictors and relationship to treatment outcome.

Holtz TH, Sternberg M, Kammerer S, Laserson KF, Riekstina V, Zarovska E, Skripconoka V, Wells CD, Leimane V. Holtz TH, et al. Among authors: wells cd. Ann Intern Med. 2006 May 2;144(9):650-9. doi: 10.7326/0003-4819-144-9-200605020-00008. Ann Intern Med. 2006. PMID: 16670134 Free article.

5

Delamanid improves outcomes and reduces mortality in multidrug-resistant tuberculosis.

Skripconoka V, Danilovits M, Pehme L, Tomson T, Skenders G, Kummik T, Cirule A, Leimane V, Kurve A, Levina K, Geiter LJ, Manissero D, Wells CD. Skripconoka V, et al. Among authors: wells cd. Eur Respir J. 2013 Jun;41(6):1393-400. doi: 10.1183/09031936.00125812. Epub 2012 Sep 27. Eur Respir J. 2013. PMID: 23018916 Free PMC article.

6

Impact of the growing HIV-1 epidemic on multidrug-resistant tuberculosis control in Latvia.

Morozova I, Riekstina V, Sture G, Wells C, Leimane V. Morozova I, et al. Int J Tuberc Lung Dis. 2003 Sep;7(9):903-6. Int J Tuberc Lung Dis. 2003. PMID: 12971677

7

Risk factors associated with default from multidrug-resistant tuberculosis treatment, South Africa, 1999-2001.

Holtz TH, Lancaster J, Laserson KF, Wells CD, Thorpe L, Weyer K. Holtz TH, et al. Among authors: wells cd. Int J Tuberc Lung Dis. 2006 Jun;10(6):649-55. Int J Tuberc Lung Dis. 2006. PMID: 16776452

8

Treatment outcome cohort analysis in an integrated DOTS and DOTS-Plus TB program in Latvia.

Riekstina V, Leimane V, Holtz TH, Leimans J, Wells CD. Riekstina V, et al. Among authors: wells cd. Int J Tuberc Lung Dis. 2007 May;11(5):585-7. Int J Tuberc Lung Dis. 2007. PMID: 17439686

9

HIV infection and multidrug-resistant tuberculosis: the perfect storm.

Wells CD, Cegielski JP, Nelson LJ, Laserson KF, Holtz TH, Finlay A, Castro KG, Weyer K. Wells CD, et al. J Infect Dis. 2007 Aug 15;196 Suppl 1:S86-107. doi: 10.1086/518665. J Infect Dis. 2007. PMID: 17624830 Review.

10

Tuberculosis along the United States-Mexico border, 1993-2001.

Schneider E, Laserson KF, Wells CD, Moore M. Schneider E, et al. Among authors: wells cd. Rev Panam Salud Publica. 2004 Jul;16(1):23-34. doi: 10.1590/s1020-49892004000700004. Rev Panam Salud Publica. 2004. PMID: 15333263

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

141 results

Search Page